Update: Yusuf Hannun from MUSC has a thoughtful letter in Nature regarding unaddressed (& not likely to be studied) potential pitfalls of the recommended changes.
Update: Science offers their take on the planned changes.
Update: On Thursday, February 21, 2008, the ACD Working Group on Peer Review made its recommendations to the full Advisory Committee to the Director (i.e., the Great Zerhouni). Larry Tabak went through the PowerPoint slides pretty much verbatim, and Nature has posted their recap. I was pleased to hear about the possible demise of the A1/A2 status and efforts to limit the number of awards per PI – and the NRR designation (not recommended for resubmission).
Of possible interest, the ACD recently added 5 new members: Mary Beckerle, PhD, Huntsman Cancer Institute (Utah); Colleen Conway-Welch, PhD, CNM, FAAN, FACNM, Vanderbilt University School of Nursing; Walter Isaacson, Aspen Institute; Thomas Kelly, MD, PhD, Sloan-Kettering Institute; and Keith Yamamoto, PhD, UCSF School of Medicine. Drs. Beckerle and Yamamoto have been serving on the Working Group on Peer Review.
